DocSym
β
Searchsearch
Search
(D68.9) Coagulation defect, unspecified
More details coming soon
734 830 in individuals diagnosis coagulation defect, unspecified confirmed
26 707 deaths with diagnosis coagulation defect, unspecified
4% mortality rate associated with the disease coagulation defect, unspecified
Diagnosis coagulation defect, unspecified is diagnosed Women are 9.01% more likely than Men
334 299
Men receive the diagnosis coagulation defect, unspecified
11 162 (3.3 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
400 531
Women receive the diagnosis coagulation defect, unspecified
15 545 (3.9 %)Died from this diagnosis.
Risk Group for the Disease coagulation defect, unspecified - Men aged 75-79 and Women aged 80-84
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any agein in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features coagulation defect, unspecified
Absence or low individual and public risk
Coagulation defect, unspecified - what does this mean
Coagulation defect, unspecified is a condition in which the body's ability to form blood clots is impaired. this can lead to increased bleeding, either spontaneously or after trauma, and can be caused by a variety of factors, such as an inherited disorder, a deficiency in clotting factors, or an underlying medical condition.
What happens during the disease - coagulation defect, unspecified
Coagulation defect, unspecified is a condition wherein the body's ability to form blood clots is impaired. this can be due to a deficiency in clotting factors, abnormal platelet function, or an imbalance in the body's clotting system. additionally, the defect can be caused by genetic factors, certain medications, or underlying medical conditions. in some cases, the cause of the defect is unknown. treatment for this condition is typically focused on reducing the risk of bleeding and managing any identified underlying cause.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete Blood Count (CBC)
- Partial Thromboplastin Time (PTT)
- Activated Partial Thromboplastin Time (aPTT)
- Prothrombin Time (PT)
- Fibrinogen Level
- Factor Assays
- D-dimer Test
- Antiphospholipid Antibody Test
- Genetic Testing
Treatment and Medical Assistance
Main goal of the treatment: To reduce the risk of bleeding and clotting complications.
- Prescribe anticoagulant medications such as warfarin, heparin, and low molecular weight heparin.
- Monitor blood levels of anticoagulants.
- Monitor patient's vital signs and watch for signs of bleeding.
- Perform regular blood tests to monitor clotting factors.
- Educate patient on the importance of taking anticoagulants as prescribed.
- Educate patient on the importance of avoiding activities that could lead to bleeding.
- Educate patient on the importance of eating a healthy diet and avoiding certain foods that can interfere with the action of anticoagulants.
- Refer patient to a hematologist for further evaluation and management.
14 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Coagulation defect, unspecified - Prevention
To prevent coagulation defect, unspecified, it is important to maintain a healthy lifestyle, including regular exercise, a balanced diet, and avoiding smoking and excessive alcohol consumption. it is also important to be aware of any family history of coagulation defects, and to seek medical advice if any symptoms or signs of the condition are present.